Novo Nordisk(MX:NOVOBN)
MX$745.000.00 (0.00%)
MX:NOVOBN
Novo Nordisk earnings date
MX$745.00
At close:0.00 (0.00%)
Novo Nordisk (NOVOBN) Q2 2026 Earnings Report
2 Followers
MX:NOVOBN Q2 2026 EPS Results
- Actual EPS
- MXN 17.17
- Consensus EPS
- MXN 13.98
- Beat/Miss
- Beat by +MXN 3.20
- One Year Ago EPS
- MXN 16.56
MX:NOVOBN Q2 2026 Revenue Results
- Actual Revenue
- MXN 218.07B
- Expected Revenue
- MXN 198.23B
- Beat/Miss
- Beat by +MXN 19.84B
- YoY Revenue Growth
- +2.12%
Earnings Announcement Details
- Quarter
- Q2 2026
- Date
- 08/04/2026
- Time
- During Market Hours
- Conference Call
- Tuesday, August 4, 2026
MX:NOVOBN Upcoming Earnings
Novo Nordisk's next earnings date is estimated for February 3, 2027, based on past reporting schedules.
Q2 2026 Earnings Call Audio
No earnings call audio is available for this earnings event.
Q2 2026 Earnings Slide Deck
No slide deck is available for this earnings event.
Q2 2026 Earnings Call Summary
No earnings call summary is available for this earnings event.
MX:NOVOBN Earnings History
| Report Date | Fiscal Quarter | Forecast / EPS | Last Year's EPS | EPS YoY Change | Press Release |
|---|---|---|---|---|---|
| Feb 03, 2027 | 2026 (Q4) | 12.53- | 16.78 | ― | ― |
| Nov 04, 2026 | 2026 (Q3) | 13.2116.09 | 12.5 | 28.67% (+3.58) | |
| Aug 04, 2026 | 2026 (Q2) | 13.9817.17 | 16.56 | 3.69% (+0.61) | |
| May 06, 2026 | 2026 (Q1) | 16.6618.42 | 18.14 | 1.53% (+0.28) | |
| Feb 03, 2026 | 2025 (Q4) | 16.3216.78 | 17.61 | -4.73% (-0.83) | |
| Nov 05, 2025 | 2025 (Q3) | 13.6112.50 | 17 | -26.47% (-4.50) | |
| Aug 06, 2025 | 2025 (Q2) | 16.4816.56 | 12.47 | 32.74% (+4.08) | |
| May 07, 2025 | 2025 (Q1) | 16.9618.14 | 15.78 | 14.96% (+2.36) | |
| Feb 05, 2025 | 2024 (Q4) | 16.6117.61 | 13.64 | 29.12% (+3.97) | |
| Nov 06, 2024 | 2024 (Q3) | 16.6617.00 | 13.89 | 22.40% (+3.11) |
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat Missed
